Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Brad Silver Stories

2013-04-18 08:31:38

Unprecedented Results Compared With Current Standard of Care BETHESDA, Md., April 18, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax(®) personalized immune therapies for solid tumor cancers, announced today that Brad Silver, an All American swimming and water polo athlete who was diagnosed with Glioblastoma multiforme (GBM) brain cancer in late 2002, and was treated with DCVax-L in March of 2003, just celebrated...